Results 181 to 190 of about 4,025 (198)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

Open Forum Infectious Diseases, 2014
Stuart Johnson, Larry H Danziger
exaly  

Hypersensitivity Reactions Associated With Fidaxomicin Use

Clinical Infectious Diseases, 2014
exaly  

Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3)

Molecular Cell, 2018
Haibo Zhang, Richard H Ebright, Richard Ebright   +2 more
exaly  

Total Synthesis of Fidaxomicin

Synfacts, 2015
openaire   +1 more source

Fidaxomicin/vancomycin

Reactions Weekly
openaire   +2 more sources

Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE)

Journal of Antimicrobial Chemotherapy, 2018
Grazyna Rydzewska, Walter Reinisch, Christoph Hogenauer   +2 more
exaly  

Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections

Clinical Therapeutics, 2012
exaly  

Fidaxomicin value for money

PharmacoEconomics & Outcomes News, 2012
openaire   +1 more source

Additional reimbursement for fidaxomicin

PharmacoEconomics & Outcomes News, 2012
openaire   +1 more source

Fidaxomicin endorsed by ESCMID

Clinical Pharmacist, 2013
openaire   +1 more source